Patents by Inventor Edward E. Beedle

Edward E. Beedle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5554640
    Abstract: This invention provides a method of selectively antagonizing-the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Aryloxypropanolamines are also claimed.
    Type: Grant
    Filed: February 8, 1995
    Date of Patent: September 10, 1996
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson, David T. Wong
  • Patent number: 5420294
    Abstract: This invention provides a method of selectively antagonizing the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Aryloxypropanolamines are also claimed.
    Type: Grant
    Filed: December 22, 1993
    Date of Patent: May 30, 1995
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson, David T. Wong
  • Patent number: 5013761
    Abstract: This invention provides a method of selectively antagonizing the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Novel aryloxypropanolamines are also claimed.
    Type: Grant
    Filed: November 8, 1989
    Date of Patent: May 7, 1991
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson, David T. Wong
  • Patent number: 4981866
    Abstract: This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: March 27, 1990
    Date of Patent: January 1, 1991
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson
  • Patent number: 4939163
    Abstract: This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: April 10, 1989
    Date of Patent: July 3, 1990
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson
  • Patent number: 4835181
    Abstract: This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: February 18, 1987
    Date of Patent: May 30, 1989
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson
  • Patent number: 4642379
    Abstract: This invention provides certain 4-acylamino benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: August 30, 1985
    Date of Patent: February 10, 1987
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson
  • Patent number: 4632939
    Abstract: This invention provides certain benzamide derivatives of the formula: ##STR1## wherein Z is bond, --CH.sub.2 --, or CHCH.sub.3 ; A is --CH.sub.2 --, or CH.sub.2 CH.sub.2 --; and represents a single or double bond; and their pharmaceutical formulations and their use as anticonvulsant agents.
    Type: Grant
    Filed: March 15, 1985
    Date of Patent: December 30, 1986
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson